Obesity-Related Glomerulopathy and Newly Diagnosed Type 2 Diabetes in Advanced CKD: A Case Report
Year: 2026
Type: preprint
Study design: Case Report
Abstract: Background: Obesity-related glomerulopathy (ORG) is characterised by glomerulomegaly, with or without an adaptive focal segmental glomerulosclerosis lesion, and its incidence is rising in parallel with the obesity epidemic. Case presentation: We report the case of a 43-year-old man with class III obesity (body mass index 40.2 kg/m²) and a 20-year history of arterial hypertension who was referred for newly detected renal impairment. He was admitted with elevated serum creatinine (261 µmol/L, eGFR 26 mL/min/1.73 m²), moderately increased proteinuria (UPCR 172.6 mg/mmol) with normal serum albumin, urinary sediment without erythrocyturia, and features of metabolic syndrome. An oral glucose tolerance test and HbA1c confirmed previously undiagnosed type 2 diabetes mellitus. Kidney biopsy showed glomerulomegaly with the perihilar variant of FSGS, superimposed on moderate arteriosclerosis and 40–50% interstitial fibrosis and tubular atrophy, without nodular diabetic glomerulosclerosis or electrondense immune deposits. Although electron microscopy showed diffuse foot-process effacement, the integrated clinicopathological findings supported ORG. After adding empagliflozin to renin–angiotensin–aldosterone system blockade, along with dietary and lipid-lowering measures, proteinuria decreased (urine protein/creatinine ratio from 172.6 to 132.8 mg/mmol), and kidney function remained stable. Conclusion: This case highlights the role of kidney biopsy in patients with obesity and advanced CKD in identifying coexisting lesions, interpreting ultrastructural findings in clinical context, and screening for diabetes in patients with CKD.
Source: Preprints.org
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: obesity-related glomerulopathy, type 2 diabetes, advanced chronic kidney disease, glomerular hypertrophy, focal segmental glomerulosclerosis, proteinuria, renal biopsy, diabetic nephropathy, empagliflozin, renin-angiotensin-aldosterone system blockade, metabolic syndrome, hypertension, diabetic glomerulosclerosis
Open Access status: green
OpenAlex ID: W7236607085
